Exane Derivatives’s Gold Fields GFI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-1
Closed -$4 681
2019
Q1
$4 Sell
1
-7,615
-100% -$29.4K ﹤0.01% 632
2018
Q4
$26.8K Hold
7,616
﹤0.01% 422
2018
Q3
$18.5K Buy
7,616
+7,359
+2,863% +$22.1K ﹤0.01% 421
2018
Q2
$924 Buy
257
+200
+351% +$748 ﹤0.01% 535
2018
Q1
$235 Sell
57
-2,382
-98% -$9.72K ﹤0.01% 528
2017
Q4
$10.5K Sell
2,439
-4,717
-66% -$19K ﹤0.01% 402
2017
Q3
$30.8K Sell
7,156
-36,127
-83% -$148K 0.01% 335
2017
Q2
$151K Sell
43,283
-60,789
-58% -$220K 0.03% 226
2017
Q1
$367K Sell
104,072
-42,337
-29% -$143K 0.08% 152
2016
Q4
$441K Buy
+146,409
New +$525K 0.09% 166
2015
Q3
Sell
-6,810
Closed -$22K 549
2015
Q2
$22K Hold
6,810
﹤0.01% 336
2015
Q1
$27.3K Buy
6,810
+877
+15% +$4.25K ﹤0.01% 346
2014
Q4
$26.9K Buy
+5,933
New +$23.7K ﹤0.01% 367

Other funds holding GFI

Exane Derivatives's GFI Position: Q2 2019 in Review

Exane Derivatives sold out of Gold Fields (GFI) in Q2 2019, closing a stake of 1 share — an estimated $4 sold.

Exane Derivatives first reported a position in GFI in Q4 2014 and held it in 13 quarters. The position peaked at $441K in Q4 2016. 149 funds tracked by Wall St. Rank hold GFI as of Q2 2019.

  • Exane Derivatives reported no remaining Gold Fields position as of Q2 2019 after selling out during the quarter.
  • Exane Derivatives sold 1 Gold Fields share in Q2 2019, an estimated $4.
  • Exane Derivatives first reported a position in Gold Fields in Q4 2014 and held it in 13 quarters.
  • Exane Derivatives's Gold Fields position peaked at $441K in Q4 2016.
  • 149 funds tracked by Wall St. Rank held Gold Fields as of Q2 2019.

Based on Exane Derivatives's 13F filing for Q2 2019, filed 12 Jul 2019.